DK13290A - Retroviral vektor - Google Patents

Retroviral vektor Download PDF

Info

Publication number
DK13290A
DK13290A DK013290A DK13290A DK13290A DK 13290 A DK13290 A DK 13290A DK 013290 A DK013290 A DK 013290A DK 13290 A DK13290 A DK 13290A DK 13290 A DK13290 A DK 13290A
Authority
DK
Denmark
Prior art keywords
transcription unit
introducing
sequence
retroviral vector
dna encoding
Prior art date
Application number
DK013290A
Other languages
English (en)
Other versions
DK13290D0 (da
Inventor
Eli Gilboa
Original Assignee
Sloan Kettering Inst Cancer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22726179&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK13290(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sloan Kettering Inst Cancer filed Critical Sloan Kettering Inst Cancer
Publication of DK13290D0 publication Critical patent/DK13290D0/da
Publication of DK13290A publication Critical patent/DK13290A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK013290A 1988-05-17 1990-01-16 Retroviral vektor DK13290A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19662888A 1988-05-17 1988-05-17
PCT/US1989/002138 WO1989011539A1 (en) 1988-05-17 1989-05-17 Retroviral vector

Publications (2)

Publication Number Publication Date
DK13290D0 DK13290D0 (da) 1990-01-16
DK13290A true DK13290A (da) 1990-03-16

Family

ID=22726179

Family Applications (1)

Application Number Title Priority Date Filing Date
DK013290A DK13290A (da) 1988-05-17 1990-01-16 Retroviral vektor

Country Status (8)

Country Link
EP (1) EP0371119B1 (da)
JP (1) JPH02504344A (da)
AT (1) ATE142268T1 (da)
AU (1) AU631554B2 (da)
CA (1) CA1335798C (da)
DE (1) DE68927089T2 (da)
DK (1) DK13290A (da)
WO (1) WO1989011539A1 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5650148A (en) * 1988-12-15 1997-07-22 The Regents Of The University Of California Method of grafting genetically modified cells to treat defects, disease or damage of the central nervous system
GB8901778D0 (en) * 1989-01-27 1989-03-15 Univ Court Of The University O Manipulatory technique
US5871958A (en) * 1989-05-25 1999-02-16 Duke University Mutant rev genes encoding transdominant repressors of HIV replication
US6251675B1 (en) * 1989-05-25 2001-06-26 Duke University Methods utilizing mutant rev genes encoding transdominant repressors of HIV replication
GB2269175A (en) * 1992-07-31 1994-02-02 Imperial College Retroviral vectors
DE69333930T8 (de) * 1993-01-22 2007-02-22 The Regents Of The University Of Colorado, Boulder Lokalisierung von therapeutischen mitteln
FR2707091B1 (fr) * 1993-06-30 1997-04-04 Cohen Haguenauer Odile Vecteur rétroviral pour le transfert et l'expression de gènes dans des cellules eucaryotes.
AU7477394A (en) * 1993-07-30 1995-03-27 University Of Medicine And Dentistry Of New Jersey Efficient gene transfer into primary lymphocytes
US5902880A (en) * 1994-08-19 1999-05-11 Ribozyme Pharmaceuticals, Inc. RNA polymerase III-based expression of therapeutic RNAs
US6146886A (en) 1994-08-19 2000-11-14 Ribozyme Pharmaceuticals, Inc. RNA polymerase III-based expression of therapeutic RNAs
JP4037446B2 (ja) 1994-09-02 2008-01-23 ゲーエスエフ − フォルシュンクスツェントルム・フューア・ウムベルト・ウント・ゲズントハイト・ゲーエムベーハー 非自己不活化性の発現標的化レトロウイルスベクタ
FR2727429B1 (fr) 1994-11-30 1997-11-28 Haguenauer Odile Cohen Lignees d'encapsidation et vecteurs d'expression pour la transcomplementation de vecteurs retroviraux defectifs
WO1996028563A1 (en) 1995-03-09 1996-09-19 Bavarian Nordic Vectors carrying therapeutic genes encoding antimicrobial peptides for gene therapy
ATE309000T1 (de) 1995-06-27 2005-11-15 Bavarian Nordic As Verkapselte zellen die virenpartikeln produzieren
US6540995B1 (en) 1996-03-27 2003-04-01 Bavarian Nordic Research Institute Gmbh Encapsulated cells producing cytochrome P450
SI0892852T1 (sl) 1996-03-27 2006-04-30 Bavarian Nordic As Inkapsulirane celice, ki eksprimirajo citokrom P450 za aktiviranje predzdravila
ATE278029T1 (de) 1998-01-06 2004-10-15 Inst Virologie Teilrechtsfaehi Rekonstituierender retroviraler vektor (recon vektor) für gezielte genexpression

Also Published As

Publication number Publication date
WO1989011539A1 (en) 1989-11-30
JPH02504344A (ja) 1990-12-13
DE68927089T2 (de) 1997-04-03
DK13290D0 (da) 1990-01-16
DE68927089D1 (de) 1996-10-10
AU3740489A (en) 1989-12-12
ATE142268T1 (de) 1996-09-15
CA1335798C (en) 1995-06-06
AU631554B2 (en) 1992-12-03
EP0371119A1 (en) 1990-06-06
EP0371119B1 (en) 1996-09-04
EP0371119A4 (en) 1990-12-05

Similar Documents

Publication Publication Date Title
DE68927089D1 (de) Retroviraler vektor
ATE317908T1 (de) Verfahren zur herstellung von rekombinanten viren
DE68924775D1 (de) Verwendungen viraler enzyme.
EP0305929A3 (en) Membranes with bound oligonucleotides and peptides
AU8223187A (en) T cell epitopes of the hepatitis b virus nucleocapsid protein
DE69637631D1 (de) Künstliche säuger chromosome
DE69300750D1 (de) Verfahren zur Herstellung von Hohlfasermembranbund.
DE3467160D1 (en) Process for the preparation of 1,1,2-trichloro-2-methyl propane
FI881025A0 (fi) Kemisk process med ett funktionellt steg som aer kaensligt foer en komponent i den inmatade stroemmen.
ATE228565T1 (de) Nukleinsäure, expressionsvektor und zusammensetzungen zur identifizierung und herstellung von rekombinanten sialyltransferasen
BR8704419A (pt) Cartucho de gas co2 pressurizado e processo de preparacao domestica de bebidas carbonatadas
DE59003144D1 (de) Destillationsanlage zur Herstellung von Wasserstoff-Peroxid.
DE3688575D1 (de) Gemilderte reduktionsreaktion zur herstellung von arylhydroxylaminen.
NO20003400D0 (no) Borevæske med invertert emulsjon, inneholdende blandinger av sekundære estere fremstilt ved omdannelse av olefiner, og fremgangsmÕte for fremstilling av slike blandinger
DE69722195D1 (de) Verfahren zur herstellung von methylmercatopropanal
NO166394C (no) Fremgangsmaate for oksydering i gassfase, samt reaktor foranvendelse ved fremgangsmaaten.
DE3784237D1 (de) Partiell oxydation von kohlenwasserstoffgasen.
NO873809D0 (no) Skip med en i skipets akterstevn anordnet propell, samt fremgangsmaate ved skipets drift.
ES2021031B3 (es) Compuesto de dioxazina que tiene un grupo reactivo tipo fibra de vinilsulfona.
ATE84018T1 (de) Verfahren zur herstellung von 1,1,-dichlor-1fluoroethan.
Gilad et al. Measurement of the 16O (pi+, pi 0p) reaction
DE68922507D1 (de) Verfahren zur Herstellung von beta-2',2'-Difluornukleosiden.
NO883566D0 (no) Forsterkningselement ved fartoeyer for offshorearbeider.
NO874574L (no) Fremgangsmaate for fremstilling av styrenert hydrokinon.
DE3770086D1 (de) Verfahren zur herstellung von 2,2-bis(4'-hydroxyphenyl)-propanen.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment